Synthetic cannabinoid compounds for treatment of epilepsy, substance addiction and Alzheimer's disease
AssigneeMyMD Pharmaceuticals, Inc.
InventorJonnie R. Williams
Life of this patent
Estimating the term…
Abstract
Synthetic cannabinoid compounds for treatment of epilepsy, substance addiction, and Alzheimer's disease by administering to an individual in need thereof a pharmaceutical composition including a compound having the structure: or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.
Claims14
A method of treating epilepsy comprising administering to an individual in need thereof a pharmaceutical composition comprising a compound having the structure:
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.
A method of treating Alzheimer's disease comprising administering to an individual in need thereof a pharmaceutical composition comprising a compound having the structure:
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.
A method of treating addiction to alcohol, tobacco, opioid, prescription drugs, cocaine, benzodiazepines, amphetamines, hallucinogens, inhalants, phencyclidine, or other illicit drug comprising administering to an individual in need thereof a pharmaceutical composition comprising a compound having the structure:
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle therefor.
Dependencies are inferred from the claim text.